Headlines
Headlines
On Invasion Anniversary, UN Says Ukraine Cannot Be Divided
Headlines
Trump's US Is Not an Ally of France, Says French Presidential Hopeful

Headlines
Russia Issues Statement Warning of Risks of Clash Between Nuclear Powers
Headlines
World Bank Report Highlights 'shockingly Large' Gap Between Gender Equality Laws and Enforcement
Putin Tells Fsb to Better Protect Energy Sector, Warns Foes Against Pushing Moscow Too Far
Date: February 24, 2026
MOSCOW, Feb 24 (Reuters) - President Vladimir Putin on Tuesday ordered the FSB security service to step up protection of Russia's energy and transport infrastructure in response to Ukrainian attacks...
Novo Nordisk to Cut US List Prices of Ozempic, Wegovy as of 2027
Date: February 24, 2026
COPENHAGEN, Feb 24 (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday it plans to slash the U.S. list prices of its blockbuster weight-loss drug Wegovy and diabetes drug Ozempic by up to 50%...
EU to Propose Permanent Ban on Russian Oil After Hungary Election, Document Shows
Date: February 24, 2026
By Lili Bayer and Kate Abnett BRUSSELS, Feb 24 (Reuters) - The European Commission will submit a legal proposal to permanently ban Russian oil imports on April 15, three days after Hungary's...
UK Sanctions New Zealand Insurer Maritime Mutual After Reuters Report
Date: February 24, 2026
By Paul Carsten and Lucy Craymer BERLIN, Feb 24 (Reuters) - Britain on Tuesday sanctioned Maritime Mutual, the New Zealand-based marine insurer that was the subject of a Reuters special report into...
UK Sanctions Two Georgian Tv Channels Over 'Russian Disinformation'
Date: February 24, 2026
TBILISI, Feb 24 (Reuters) - Britain introduced sanctions against two pro-government television channels in Georgia on Tuesday, accusing them of spreading deliberately misleading information about...
Novo Nordisk to Halve US List Price of Wegovy From 2027
Date: February 24, 2026
Feb 24 (Reuters) - Danish drugmaker Novo Nordisk plans to slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Wall Street...
